---
title: "ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial | BAYRY Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288154404.md"
description: "ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial | BAYRY Stock News"
datetime: "2026-05-30T13:25:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288154404.md)
  - [en](https://longbridge.com/en/news/288154404.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288154404.md)
generator: "portal-rs"
---

# ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial | BAYRY Stock News

ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial | BAYRY Stock News

### Related Stocks

- [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md)
- [ALPMY.US](https://longbridge.com/en/quote/ALPMY.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIS.US](https://longbridge.com/en/quote/BIS.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BAYZF.US](https://longbridge.com/en/quote/BAYZF.US.md)

## Related News & Research

- [Bayer, Pharmacity partner with VINAFPA on reproductive health education](https://longbridge.com/en/news/297121266.md)
- [Bayer says Japan approves sevabertinib for HER2-mutant NSCLC](https://longbridge.com/en/news/296745277.md)
- [Wealthfront Advisers LLC Reduces Position in Pfizer Inc. $PFE](https://longbridge.com/en/news/296697632.md)
- [Prediction: This Is Where Pfizer Stock Will Be in 2030](https://longbridge.com/en/news/296683959.md)
- [Astellas doses first patient in Phase 3 study of ASP2138 for CLDN18.2-positive gastric, GEJ cancer](https://longbridge.com/en/news/296837470.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**